NCT07312370 2025-12-31
ESUS-ESD
LanZhou University
Phase 4 Not yet recruiting
Clinical Trials
28 trialsNCT07139366 2025-12-02
Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment
Xijing Hospital of Digestive Diseases
Phase 4 Recruiting
NCT07144657 2025-08-27
GastricMALToma
National Taiwan University Hospital
Phase 2 Not yet recruiting
NCT04865731 2025-08-06
Dermaprazole Cream for Radiation Dermatitis in Head and Neck Cancer
The University of Texas Health Science Center at San Antonio
Phase 2 Completed
NCT05742568 2025-07-03
Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology
Xijing Hospital of Digestive Diseases
Phase 4 Completed
NCT06168084 2025-07-03
Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy
Xijing Hospital of Digestive Diseases
Phase 4 Completed
NCT00357682 2025-05-01
AspECT
University of Oxford
Phase 3 Completed
NCT06120803 2025-04-13
EERENs
Rush University Medical Center
Phase 2 Recruiting
NCT06810492 2025-03-17
The Efficacy and Safety of CDK4/6 Inhibitors in Combination with Endocrine Therapy in the Neoadjuvant Treatment
Hubei Cancer Hospital
Phase NA Not yet recruiting
NCT06378658 2024-07-05
A Study to Learn About How Food and Esomeprazole Affect the Level of BAY2927088 in the Blood When Taken Together in Healthy Participants
Bayer
Phase 1 Completed
NCT04678492 2023-01-31
Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy
Xijing Hospital of Digestive Diseases
Phase 4 Completed
NCT05061563 2022-03-17
A Study to Learn How a Proton Pump Inhibitor Affects the Way Elinzanetant (BAY 3427080) Moves Into, Through and Out of the Body, and How Much of it Gets Absorbed by the Body When Taken as a Single and Small Radioactive Dose in Healthy Adults
Bayer
Phase 1 Completed
NCT05100446 2021-10-29
Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicobacter Pylori Infection
Unidade Local de Saúde do Alto Ave, EPE
Phase EARLY_PHASE1 Unknown
NCT04329000 2020-04-03
On-demand PPI Therapy is Effective on Controlling Symptoms in Patients With Barrett's Esophagus.
Kaohsiung Veterans General Hospital.
Phase NA Completed
NCT01844583 2019-03-25
Safety, Tolerability and Pharmacokinetic (PK) of Concomitant Esomeprazole and Rifampin, and QT Study on Single and Multiple-doses of Alisertib
Takeda
Phase 1 Completed
NCT00206440 2018-12-06
NEXIUM
Baylor Breast Care Center
Phase 3 Terminated
NCT02800330 2018-08-02
REGORA
Erasmus Medical Center
Phase 4 Completed
NCT00222079 2017-12-14
Evaluation of Esomeprazole in Treating Gastro-esophageal Reflux Disease (GERD) in Head and Neck Cancer Patients Exposed to Radiation Therapy
University of Iowa
Phase NA Terminated
NCT00849329 2017-11-14
A Study to Examine the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Lapatinib in Subjects With Metastatic ErbB2 Positive Breast Cancer
GlaxoSmithKline
Phase 1 Completed
NCT02730533 2017-07-21
The Efficacy of Esomeprazole Premedication on Intraoperative Bleeding During Gastric ESD
Xijing Hospital of Digestive Diseases
Phase NA Completed
NCT01069081 2015-03-06
Docetaxel and Cisplatin Chemotherapy With or Without High Dose Proton Pump Inhibitor in Metastatic Breast Cancer
Fudan University
Phase 2 Completed
NCT00474903 2014-07-02
Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus
National Cancer Institute (NCI)
Phase 2 Completed
NCT00473980 2012-04-02
Preoperative Non-steroidal Anti-inflammatory Drugs(NSAID) to Colorectal Cancer Patients
Göteborg University
Phase 4 Completed
NCT00942175 2012-02-03
A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.
Takeda
Phase 1 Completed
NCT00637988 2011-01-21
Barrett's Esophagus - 315 - 3 Way Cross Over
AstraZeneca
Phase 4 Completed
NCT00079833 2010-11-19
Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome
AstraZeneca
Phase 3 Completed
NCT00216788 2010-03-16
The Effect of Nexium on Transmucosal Esophageal Leak
Main Line Health
Phase 1 Unknown
NCT00352261 2009-03-26
An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients
AstraZeneca
Phase 4 Completed